{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:55:56Z","timestamp":1793436956781,"version":"4.5.0"},"reference-count":101,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chemotherapeutic agents and radiotherapy are highly effective in treating malignancies. However, they carry a significant risk of harming the gonads and may lead to endocrine dysfunction and reproductive issues. This review outlines the molecular mechanisms of gonadotoxic therapies, focusing on radiation, alkylating agents, and platinum compounds. It discusses the loss of PMFs due to gonadotoxic exposure, including DNA double-strand breaks, oxidative stress, and dysregulated signaling pathways like PI3K\/PTEN\/Akt\/mTOR and TAp63-mediated apoptosis. Furthermore, it explores strategies to mitigate gonadal damage, including GnRH agonists, AMH, imatinib, melatonin, sphingolipid metabolites, G-CSF, mTOR inhibitors, AS101, and LH. These therapies, paired with existing fertility preservation methods, could safeguard reproductive and hormonal functions and improve the quality of life for young cancer patients. Despite the progress made in recent years in understanding gonadotoxic mechanisms, gaps remain due to questionable reliance on mouse models and the lack of models replicating human ovarian dynamics. Long-term studies are vital for wider analyses and exploration of protective strategies based on various animal models and clinical trials. It is essential to verify that these substances do not hinder the anti-cancer effectiveness of treatments or cause lasting DNA changes in granulosa cells, raising the risk of miscarriages and infertility.<\/jats:p>","DOI":"10.3390\/ijms26157314","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T10:25:34Z","timestamp":1753784734000},"page":"7314","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fertility Protection in Female Cancer Patients: From Molecular Mechanisms of Gonadotoxic Therapies to Pharmacotherapeutic Possibilities"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6344-0204","authenticated-orcid":false,"given":"Weronika","family":"Zaj\u0105czkowska","sequence":"first","affiliation":[{"name":"Division of Gynaecology, Poznan University of Medical Sciences, Polna 33, 60535 Poznan, Poland"},{"name":"Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60812 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Buda","sequence":"additional","affiliation":[{"name":"Gynaecological and Obstetric Clinical Hospital of Poznan University of Medical Sciences, Polna 33, 60535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witold","family":"K\u0119dzia","sequence":"additional","affiliation":[{"name":"Division of Gynaecology, Poznan University of Medical Sciences, Polna 33, 60535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0218-6841","authenticated-orcid":false,"given":"Karina","family":"Kapczuk","sequence":"additional","affiliation":[{"name":"Division of Gynaecology, Poznan University of Medical Sciences, Polna 33, 60535 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"ref_1","unstructured":"Howlader, N., Noone, A.M., Krapcho, M., Miller, D., Brest, A., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., and Lewis, D.R. (2020, April 09). SEER Cancer Statistics Review, 1975\u20132016, Available online: https:\/\/seer.cancer.gov\/csr\/1975_2016."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.297.24.2705","article-title":"Medical assessment of adverse health outcomes in long-term survivors of childhood cancer","volume":"297","author":"Geenen","year":"2007","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/djj243","article-title":"Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study","volume":"98","author":"Sklar","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_4","first-page":"109","article-title":"Effect of radiation on the human reproductive system","volume":"101","author":"Shalet","year":"1993","journal-title":"Environ. Health Perspect."},{"key":"ref_5","first-page":"929","article-title":"Placenta percreta and uterine rupture associated with prior whole body radiation therapy","volume":"98","author":"Norwitz","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000067835","article-title":"Impact of Cancer therapy on the reproductive Axis","volume":"59","year":"2003","journal-title":"Horm. Res. Paediatr."},{"key":"ref_7","first-page":"55","article-title":"Hypothalamic dysfunction after chemotherapy","volume":"17","author":"Rose","year":"2004","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wallace, W.H., and Kelsey, T.W. (2010). Human ovarian reserve from conception to the menopause. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008772"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy induced damage to ovary: Mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol. Lond. Engl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.fertnstert.2015.11.020","article-title":"Menses resumption after cancer treatment-induced amenorrhea occurs early or not at all","volume":"105","author":"Jacobson","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE Guideline: Management of women with premature ovarian insufficiency","volume":"31","author":"Webber","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"ESHRE Guideline Group on Female Fertility Preservation, Anderson, R.A., Amant, F., Braat, D., D\u2019Angelo, A., Chuva de Sousa Lopes, S.M., Demeestere, I., Dwek, S., Frith, L., and Lambertini, M. (2020). ESHRE guideline: Female fertility preservation. Hum. Reprod. Open, 2020, hoaa052.","DOI":"10.1093\/hropen\/hoaa052"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40738-021-00105-7","article-title":"Onco-fertility and personalized testing for potential for loss of ovarian reserve in patients undergoing chemotherapy: Proposed next steps for development of genetic testing to predict changes in ovarian reserve","volume":"7","author":"Sun","year":"2021","journal-title":"Fertil. Res. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<697::AID-CNCR20>3.0.CO;2-J","article-title":"Having children after cancer","volume":"86","author":"Schover","year":"1999","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.fertnstert.2013.03.030","article-title":"Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: A review of 60 cases of reimplantation","volume":"99","author":"Donnez","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humupd\/dmac003","article-title":"Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: A systematic review and individual patient data meta-analysis","volume":"28","author":"Khattak","year":"2022","journal-title":"Hum. Reprod. Update"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1073\/pnas.1700337114","article-title":"A win-win for women\u2019s reproductive health: A nonsteroidal contraceptive and fertoprotective neoadjuvant","volume":"114","author":"Woodruff","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/oxfordjournals.humrep.a137570","article-title":"Accelerated disappearance of ovarian follicles in mid-life: Implications for forecasting menopause","volume":"7","author":"Faddy","year":"1992","journal-title":"Hum. Reprod."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tem.2009.10.001","article-title":"Mechanisms maintaining the dormancy and survival of mammalian primordial follicles","volume":"21","author":"Reddy","year":"2010","journal-title":"Trends. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"bnaa020","DOI":"10.1210\/endrev\/bnaa020","article-title":"Implications of Nonphysiological Ovarian Primordial Follicle Activation for Fertility Preservation","volume":"41","author":"Grosbois","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcp.30613","article-title":"Role of autophagy in follicular development and maintenance of primordial follicular pool in the ovary","volume":"237","author":"Bhardwaj","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e1589","DOI":"10.1038\/cddis.2014.559","article-title":"Germ cell-specific Atg7 knockout results in primary ovarian insufficiency in female mice","volume":"6","author":"Song","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1530\/REP-10-0489","article-title":"Autophagy is a cell survival program for female germ cells in the murine ovary","volume":"141","author":"Gawriluk","year":"2011","journal-title":"Reproduction"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00030.2009","article-title":"Regulation of mammalian autophagy in physiology and pathophysiology","volume":"90","author":"Ravikumar","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1210\/jc.2012-3995","article-title":"Reproductive and lifestyle determinants of anti-M\u00fcllerian hormone in a large population-based study","volume":"98","author":"Verschuren","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Kelsey, T.W., Hua, C.H., Wyatt, A., Indelicato, D., and Wallace, W.H. (2022). A predictive model of the effect of therapeutic radiation on the human ovary. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0277052"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"543531","DOI":"10.4061\/2010\/543531","article-title":"DNA damage induced by alkylating agents and repair pathways","volume":"2010","author":"Kondo","year":"2010","journal-title":"J. Nucleic. Acids."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4161\/cbt.23761","article-title":"Chemotherapy induced DNA damage response: Convergence of drugs and pathways","volume":"14","author":"Woods","year":"2013","journal-title":"Cancer Biol. Ther."},{"key":"ref_30","first-page":"84","article-title":"Doxorubicin, DNA torsion, and chromatin dynamics","volume":"1845","author":"Yang","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/humupd\/dmy002","article-title":"The importance of DNA repair for maintaining oocyte quality in response to anti-cancer treatments, environmental toxins and maternal ageing","volume":"24","author":"Winship","year":"2018","journal-title":"Hum. Reprod. Update"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kim, S., Kim, S.W., Han, S.J., Lee, S., Park, H.T., Song, J.Y., and Kim, T. (2021). Molecular mechanism and prevention strategy of chemotherapy- and radiotherapy-induced ovarian damage. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147484"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molcel.2012.08.017","article-title":"DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa","volume":"48","author":"Kerr","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41419-019-1961-y","article-title":"Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility","volume":"10","author":"Bellusci","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.1247671","article-title":"Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway","volume":"343","author":"Rinaldi","year":"2014","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41594-018-0035-7","article-title":"Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63","volume":"25","author":"Tuppi","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41419-018-0633-7","article-title":"Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility","volume":"9","author":"Nguyen","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Gebel, J., Tuppi, M., S\u00e4nger, N., Schumacher, B., and D\u00f6tsch, V. (2020). DNA Damaged Induced Cell Death in Oocytes. Molecules, 25.","DOI":"10.3390\/molecules25235714"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","article-title":"Adriamycin. A new anticancer drug with significant clinical activity","volume":"80","author":"Blum","year":"1974","journal-title":"Ann. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chen, X.Y., Xia, H.X., Guan, H.Y., Li, B., and Zhang, W. (2016). Follicle Loss and Apoptosis in Cyclophosphamide-Treated Mice: What\u2019s the Matter?. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060836"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.rbmo.2016.10.005","article-title":"Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro","volume":"34","author":"Lande","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/molehr\/gaaa043","article-title":"Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: Road to developing therapeutics for fertility preservation and reversing ovarian aging","volume":"26","author":"Szymanska","year":"2020","journal-title":"Mol. Hum. Reprod."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/humrep\/16.4.632","article-title":"Administration of cyclophosphamide at different stages of follicular maturation in mice: Effects on reproductive performance and fetal malformations","volume":"16","author":"Meirow","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.1617233114","article-title":"mTORC1\/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy","volume":"114","author":"Goldman","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/hmg\/ddt486","article-title":"Two classes of ovarian primordial follicles exhibit distinct developmental dynamics and physiological functions","volume":"23","author":"Zheng","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/humrep\/dead013","article-title":"Impact of first chemotherapy exposure on follicle activation and survival in human cryopreserved ovarian tissue","volume":"38","author":"Devos","year":"2023","journal-title":"Hum. Reprod."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Titus, S., Szymanska, K.J., Musul, B., Turan, V., Taylan, E., Garcia-Milian, R., Mehta, S., and Oktay, K. (2021). Individual-oocyte transcriptomic analysis shows that genotoxic chemotherapy depletes human primordial follicle reserve in vivo by triggering proapoptotic pathways without growth activation. Sci. Rep., 11.","DOI":"10.1038\/s41598-020-79643-x"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/humrep\/deaf024","article-title":"Does gonadotoxic chemotherapy deplete the ovarian reserve through activation of primordial follicles?","volume":"40","author":"Erden","year":"2025","journal-title":"Hum. Reprod."},{"key":"ref_50","first-page":"18","article-title":"Timing your apoptosis assays","volume":"16","author":"Sundquist","year":"2006","journal-title":"Protoc. Appl. Guid."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1158\/0008-5472.CAN-07-2042","article-title":"A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve","volume":"67","author":"Oktem","year":"2007","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10815-019-01507-9","article-title":"Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects","volume":"36","author":"Roness","year":"2019","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-M\u00fcllerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-M\u00fcllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2016.05.019","article-title":"Intra-cellular mechanism of antiM\u00fcllerian hormone (AMH) in regulation of follicular development","volume":"433","author":"Hayes","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","first-page":"1278","article-title":"AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice","volume":"33","author":"Sonigo","year":"2018","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e23506","DOI":"10.1096\/fj.202302141R","article-title":"Anti-M\u00fcllerian hormone induces autophagy to preserve the primordial follicle pool in mice","volume":"38","author":"Boumerdassi","year":"2024","journal-title":"FASEB J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fertnstert.2015.11.043","article-title":"Prevention of chemotherapy-induced ovarian damage","volume":"105","author":"Roness","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.fertnstert.2023.08.380","article-title":"Administration of modified rna encoding anti-mullerian hormone (modrna-amh) before cyclophosphamide bridges protein loss until resumption of secretion by a critical mass of growing follicles","volume":"120","author":"Man","year":"2023","journal-title":"Fertil. Steril."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Nenoi, M. (2012). Melatonin for protection against ionizing radiation. Current Topics in Ionizing Radiation Research, InTech.","DOI":"10.5772\/2027"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Amer, M.E., Othman, A.I., Abozaid, H.M., and El-Missiry, M.A. (2022). Utility of melatonin in mitigating ionizing radiation-induced testis injury through synergistic interdependence of its biological properties. Biol. Res., 55.","DOI":"10.1186\/s40659-022-00401-6"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-079X.2005.00258.x","article-title":"Melatonin in the treatment of cancer: A systematic review of randomized controlled trials and meta-analysis","volume":"39","author":"Mills","year":"2005","journal-title":"J. Pineal Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jpi.12316","article-title":"Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN\/AKT\/FOXO3a pathway activation in the mouse ovary","volume":"60","author":"Jang","year":"2016","journal-title":"J. Pineal Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e12432","DOI":"10.1111\/jpi.12432","article-title":"Synergistic effect of melatonin and ghrelin in preventing cisplatin-induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27Kip1promoter in primordial follicles","volume":"63","author":"Jang","year":"2017","journal-title":"J. Pineal Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"15593258251323796","DOI":"10.1177\/15593258251323796","article-title":"The Mitigating Effect of Melatonin Against Radiation-Induced Inflammation and Disturbance of Reproductive Hormones in Female Albino Rats","volume":"23","author":"Shedid","year":"2025","journal-title":"Dose-Response"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1538\/expanim.18-0042","article-title":"Protective effect of a mechanistic target of rapamycin inhibitor on an in vivo model ofcisplatin-induced ovarian gonadotoxicity","volume":"67","author":"Tanaka","year":"2018","journal-title":"Exp. Anim."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/humrep\/deae085","article-title":"Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model","volume":"39","author":"Tanaka","year":"2024","journal-title":"Hum. Reprod."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/humrep\/dead064","article-title":"Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve","volume":"38","author":"Kashi","year":"2023","journal-title":"Hum. Reprod."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Bindels, J., Squatrito, M., Bernet, L., Nisolle, M., and Munaut, C. (2025). Ovarian cryopreservation with rapamycin improves fertility restoration in a murine orthotopic transplantation model. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-94588-9"},{"key":"ref_71","first-page":"185ra62","article-title":"Cyclophosphamide triggers follicle activation and \u00ab burnout \u00bb; AS101 prevents follicle loss and preserves fertility","volume":"5","author":"Roness","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8928604","DOI":"10.1155\/2017\/8928604","article-title":"The Natural Carotenoid Crocetin and the Synthetic Tellurium Compound AS101 Protect the Ovary against Cyclophosphamide by Modulating SIRT1 and Mitochondrial Markers","volume":"2017","author":"Rossi","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm.2033","article-title":"Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy induced death","volume":"15","author":"Gonfloni","year":"2009","journal-title":"Nat. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Morgan, S., Lopes, F., Gourley, C., Anderson, R.A., and Spears, N. (2013). Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070117"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/cdd.2013.31","article-title":"Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network","volume":"20","author":"Kim","year":"2013","journal-title":"Cell Death Differ."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41419-018-1026-7","article-title":"C-Abl is not act\u0131vated in DNA damage induced and Tap63-mediated oocyte apoptos\u0131s in human ovary","volume":"9","author":"Bildik","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2889","article-title":"Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Kerr","year":"2012","journal-title":"Nat. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.fertnstert.2007.03.065","article-title":"Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model?","volume":"89","author":"Kaya","year":"2008","journal-title":"Fertil. Steril."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Zhao, J., Zhang, S., Chen, L., Liu, X., Su, H., Chen, L., Yang, L., and Zhang, H. (2020). Sphingosine 1-phosphate protects against radiation-induced ovarian injury in female rats\u2014Impact on mitochondrial-related genes. Reprod. Biol. Endocrinol., 18.","DOI":"10.1186\/s12958-020-00659-z"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.reprotox.2022.12.002","article-title":"Sphingosine 1-phosphate alleviates radiation-induced ferroptosis in ovarian granulosa cells by upregulating glutathione peroxidase 4","volume":"115","author":"Zhao","year":"2023","journal-title":"Reprod Toxicol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/det391","article-title":"Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death","volume":"29","author":"Li","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/mrd.23043","article-title":"Sphingosine-1-phosphate reduces atresia of primordial follicles occurring during slow-freezing and thawing of human ovarian cortical strips","volume":"85","author":"Guzel","year":"2018","journal-title":"Mol. Reprod. Dev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/humrep\/dey045","article-title":"Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure","volume":"33","author":"Pascuali","year":"2018","journal-title":"Hum. Reprod."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/1933719117741376","article-title":"The Impact of a Long-Acting Oral Sphingosine-1-Phosphate Analogue on Ovarian Aging in a Rat Model","volume":"25","author":"Mumusoglu","year":"2018","journal-title":"Reprod. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/cdd.2016.97","article-title":"LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse","volume":"24","author":"Rossi","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"deac106.047","DOI":"10.1093\/humrep\/deac106.047","article-title":"O-265Luteinizing hormone is able to protect reproductive health in cancer patients","volume":"37","author":"Lamsira","year":"2022","journal-title":"Hum. Reprod."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/molehr\/gay005","article-title":"Both in vivo FSH depletion and follicular exposure to gonadotrophin-releasing hormone analogues in vitro are not effective to prevent follicular depletion during chemotherapy in mice","volume":"24","author":"Horicks","year":"2018","journal-title":"Mol. Hum. Reprod."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1634\/theoncologist.12-9-1044","article-title":"How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries","volume":"12","author":"Blumenfeld","year":"2007","journal-title":"Oncologist"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1179558119870163","DOI":"10.1177\/1179558119870163","article-title":"Fertility preservation using GnRH agonists: Rationale, possible mechanisms, and explanation of controversy","volume":"13","author":"Blumenfeld","year":"2019","journal-title":"Clin. Med. Insights Reprod. Health"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1179558119864584","DOI":"10.1177\/1179558119864584","article-title":"Potential mechanisms of ovarian protection with gonadotropin-releasing hormone agonist in breast Cancer patients: A review","volume":"13","author":"Poggio","year":"2019","journal-title":"Clin. Med. Insights Reprod. Health"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ctrv.2018.11.006","article-title":"Ovarian protection with gonadotropinreleasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application","volume":"72","author":"Lambertini","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"ref_92","first-page":"102335","article-title":"Gonadotropin Releasing Hormone agonist (GnRHa) during chemotherapy and post-cancer childbirths\u2014A Nationwide population-based cohort study of 24,922 women diagnosed with cancer in Sweden","volume":"67","author":"Kieler","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e078023","DOI":"10.1136\/bmjopen-2023-078023","article-title":"ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden\u2014A phase III randomised double-blinded placebo-controlled study","volume":"13","author":"Bergh","year":"2023","journal-title":"BMJ Open"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.fertnstert.2013.01.135","article-title":"Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insuffciency in female mice treated with alkylating chemotherapy","volume":"99","author":"McGuire","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3802\/jgo.2014.25.4.328","article-title":"Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model","volume":"25","author":"Akdemir","year":"2014","journal-title":"J. Gynecol. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMc0707841","article-title":"Primary ovarian insufficiency associated with imatinib therapy","volume":"358","author":"Christopoulos","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1634\/theoncologist.2011-0137","article-title":"Will imatinib compromise reproductive capacity?","volume":"16","author":"Zamah","year":"2011","journal-title":"Oncologist"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1096\/fj.04-3496fje","article-title":"Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils","volume":"19","author":"Ohki","year":"2005","journal-title":"FASEB J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1573403X14666181031115118","article-title":"Application of G-CSF in Congestive Heart Failure Treatment","volume":"15","author":"Pourtaji","year":"2019","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/80442","article-title":"Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy","volume":"6","author":"Morita","year":"2000","journal-title":"Nat. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.bcp.2006.06.015","article-title":"The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: Association with the Akt\/survivin pathway","volume":"72","author":"Hayun","year":"2006","journal-title":"Biochem. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7314\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:17:56Z","timestamp":1760033876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":101,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157314"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157314","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]}}}